CTIS2023-505546-26-00进行中（未招募）1 期
SAD and MAD of VENT-02 in healthy volunteers
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 86
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
尚未招募
2 期
Ayurvedic Management on Memory ImpairmentCTRI/2019/05/019372All India Institute of Ayurveda
已完成
不适用
se of nitrous oxide for laparoscopic cholecystectomycholelithiasis.Calculus of gallbladder without cholecystitisIRCT138806092389N1Jundi Shapur Medical University64
进行中（未招募）
1 期
EFFECT OF V0251 IN ACUTE VERTIGO. A RANDOMISED DOUBLE-BLIND PLACEBO CONTROLLED STUDY.V0251 is a new antivertiginous agent which is being developed for the treatment of symptomatic vertiginous crisis.MedDRA version: 14.1 Level: PT Classification code 10047340 Term: Vertigo System Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2011-003412-23-ESPierre Fabre Médicament - IRPF
进行中（未招募）
1 期
EFFECT OF V0251 IN ACUTE VERTIGO. A RANDOMISED DOUBLE-BLIND PLACEBO CONTROLLED STUDY.V0251 is a new antivertiginous agent which is being developed for the treatment of symptomatic vertiginous crisis.MedDRA version: 14.0 Level: PT Classification code 10047340 Term: Vertigo System Organ Class: 10013993 - Ear and labyrinth disordersEUCTR2011-003412-23-FRPierre Fabre Médicament - IRPF
已完成
不适用
To compare complications after PVE in patients with ductal CCC versus CRC liver metastases and identify possible predictive factorscolorectal carcinoma, cholangiocellular carcinomaDRKS00028692Klinik für diagnostische und interventionelle Radiologie160